Lexeo Therapeutics nets $85m Series A

Lexeo Therapeutics, a clinical-stage gene therapy company, has raised $85 million in Series A financing.

Lexeo Therapeutics, a clinical-stage gene therapy company, has raised $85 million in Series A financing. Longitude Capital and Omega Funds led the round.

Source: Press Release